MARKET

BDTX

BDTX

Black Diamond Therapeutics, Inc.
NASDAQ
2.215
-0.040
-1.77%
Opening 14:01 02/09 EST
OPEN
2.280
PREV CLOSE
2.255
HIGH
2.280
LOW
2.170
VOLUME
558.58K
TURNOVER
--
52 WEEK HIGH
4.940
52 WEEK LOW
1.195
MARKET CAP
126.20M
P/E (TTM)
6.10
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at BDTX last week (0202-0206)?
Weekly Report · 10h ago
Weekly Report: what happened at BDTX last week (0126-0130)?
Weekly Report · 02/02 09:30
Weekly Report: what happened at BDTX last week (0119-0123)?
Weekly Report · 01/26 09:30
Weekly Report: what happened at BDTX last week (0112-0116)?
Weekly Report · 01/19 09:33
Black Diamond Theraptcs Is Maintained at Overweight by Piper Sandler
Dow Jones · 01/16 16:20
Black Diamond Theraptcs Price Target Cut to $8.00/Share From $9.00 by Piper Sandler
Dow Jones · 01/16 16:20
Piper Sandler Maintains Overweight on Black Diamond Therapeutic, Lowers Price Target to $8
Benzinga · 01/16 16:11
Black Diamond Therapeutics price target lowered to $8 from $9 at Piper Sandler
TipRanks · 01/16 11:55
More
About BDTX
Black Diamond Therapeutics, Inc. is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. The Company’s MasterKey therapies are designed to address a broad spectrum of genetically defined tumors, overcome resistance, minimize wild-type mediated toxicities, and be brain penetrant to treat central nervous system disease. The Company is advancing a Phase 2 NSCLC trial of BDTX-1535, a brain-penetrant fourth-generation epidermal growth factor receptor (EGFR) MasterKey inhibitor targeting EGFR-mutant NSCLC and glioblastoma. Its BDTX-4933 pipeline product is out-licensed to Servier. BDTX-4933 is designed to target RAS and RAF alterations in solid tumors. It is exploring partnership opportunities for its FGFR2/3 selective development candidate BDTX-4876.

Webull offers Black Diamond Therapeutics Inc stock information, including NASDAQ: BDTX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BDTX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BDTX stock methods without spending real money on the virtual paper trading platform.